Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-03629 |
LL-F 28249lambda (102042-12-6) Inquiry |
|
LL-F 28249lambda is a macrolide antibiotic with parasitic action from Streptomyces Cyaneogriseus sp. Noncyanogenus. |
||
BBF-03630 | ||
LL-Z 1220 is a natural antibiotic which contains a cyclohexene diepoxide ring system. |
||
BBF-03631 | ||
It is an anthracycline antibiotic derived from Nocardia brasiliensis IFM-0075. |
||
BBF-03632 | ||
M-230B is originally isolated from Myxococcus xanthus M516E. It has anti-gram-negative and weak anti-gram-positive activity. |
||
BBF-03633 | ||
It is produced by the strain of Micromonospora capillate MCRL 0940. M-4365 A1 is mainly resistant to Gram-positive bacteria and mycoplasma, and cross-resistance with other macrolide antibiotics. |
||
BBF-03634 | ||
It is produced by the strain of Micromonospora capillate MCRL 0940. M-4365 G1 is mainly resistant to Gram-positive bacteria and mycoplasma, and cross-resistance with other macrolide antibiotics. And it also has a certain anti-Gram-negative bacteria activity. |
||
BBF-03635 | ||
It is produced by the strain of Micromonospora capillate MCRL 0940. M-4365 G2 is mainly resistant to Gram-positive bacteria and mycoplasma, and cross-resistance with other macrolide antibiotics. |
||
BBF-03636 | ||
Tetronasin is extracted from Streptomyces longisporoflavus. It has anti-gram-positive bacteria and anti-eimeria tenella activity. |
||
BBF-03637 | ||
MA144 G2 is originally isolated from Streptomyces galilaeus MA144M1. It has anti-gram-positive bacteria and tumor effects. |
||
BBF-03638 | ||
MA144 M1 is originally isolated from Streptomyces galilaeus MA144M1. It has anti-gram-positive bacteria and tumor effects. |
||
BBF-03639 | ||
MA144 M2 is originally isolated from Streptomyces galilaeus MA144M1. It has anti-gram-positive bacteria and tumor effects. |
||
BBF-03640 | ||
MA144 U1 is originally isolated from Streptomyces galilaeus MA144M1. It has anti-gram-positive bacteria and tumor effects. |
||
BBF-03641 | ||
MA144 S1 is originally isolated from Streptomyces galilaeus MA144M1. It has anti-gram-positive bacteria and tumor effects. |
||
BBF-03642 | ||
MC-031, an inhibitor of cholesterol biosynthesis, is produced by the strain of Streptomyces sp. A3761. It inhibited the synthesis of cholesterol from Mevalonic acid with IC50 of 10.6×10-5 mol/L. It also showed weak anti-gram-positive bacteria activity and inhibited the growth of HL-60 cells. |
||
BBF-03643 | ||
MC-032, an inhibitor of cholesterol biosynthesis, is produced by the strain of Streptomyces sp. A3761. It inhibited the synthesis of cholesterol from Mevalonic acid with IC50 of 10.5×10-5 mol/L. It also showed weak anti-gram-positive bacteria activity and inhibited the growth of HL-60 cells. |
||
BBF-03644 | ||
MC-033, an inhibitor of cholesterol biosynthesis, is produced by the strain of Streptomyces sp. A3761. It inhibited the synthesis of cholesterol from Mevalonic acid with IC50 of 1.06×10-5 mol/L. It also showed weak anti-gram-positive bacteria activity and inhibited the growth of HL-60 cells. |
||
BBF-03645 | ||
MC-034, an inhibitor of cholesterol biosynthesis, is produced by the strain of Streptomyces sp. A3761. It inhibited the synthesis of cholesterol from Mevalonic acid with IC50 of 18.3×10-5 mol/L. It also showed weak anti-gram-positive bacteria activity and inhibited the growth of HL-60 cells. |
||
BBF-03646 | ||
It is originally isolated from Streptomyces pactum. Mer-A2026A has the function of vasodilator and hypotension. |
||
BBF-03647 | ||
It is originally isolated from Streptomyces pactum. Mer-A2026B has the function of vasodilator and hypotension. |
||
BBF-03648 | ||
It is originally isolated from Metarrhizium sp. f3. And it is cytotoxic to some human tumor cells, such as K562, HT29, MCF7 and HT1080 cells. |